Trade names or approved names. Part II. Points of view. The pharmaceutical company.
D003365:Costs and Cost Analysis; D004345:Drug Industry; D011307:Drug Prescriptions; D010330:Patents as Topic; D012106:Research; D013222:State Medicine; D009626:Terminology as Topic; D013810:Therapeutic Equivalency; D006113:United Kingdom